 |
PDBsum entry 1g0d
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Crystal structure of red sea bream transglutaminase.
|
 |
|
Authors
|
 |
K.Noguchi,
K.Ishikawa,
Yokoyama ki,
T.Ohtsuka,
N.Nio,
E.Suzuki.
|
 |
|
Ref.
|
 |
J Biol Chem, 2001,
276,
12055-12059.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The crystal structure of the tissue-type transglutaminase from red sea bream
liver (fish-derived transglutaminase, FTG) has been determined at 2.5-A
resolution using the molecular replacement method, based on the crystal
structure of human blood coagulation factor XIII, which is a transglutaminase
zymogen. The model contains 666 residues of a total of 695 residues, 382 water
molecules, and 1 sulfate ion. FTG consists of four domains, and its overall and
active site structures are similar to those of human factor XIII. However,
significant structural differences are observed in both the acyl donor and acyl
acceptor binding sites, which account for the difference in substrate
preferences. The active site of the enzyme is inaccessible to the solvent,
because the catalytic Cys-272 hydrogen-bonds to Tyr-515, which is thought to be
displaced upon acyl donor binding to FTG. It is postulated that the binding of
an inappropriate substrate to FTG would lead to inactivation of the enzyme
because of the formation of a new disulfide bridge between Cys-272 and the
adjacent Cys-333 immediately after the displacement of Tyr-515. Considering the
mutational studies previously reported on the tissue-type transglutaminases, we
propose that Cys-333 and Tyr-515 are important in strictly controlling the
enzymatic activity of FTG.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Schematic ribbon drawings of FTG (left) and human
factor XIII (right). Helices and sheets are colored red and
blue, respectively. Both TGases consist of four domains: -sandwich,
core, barrel 1, and barrel 2 from the N terminus. Human factor
XIII has an activation peptide (green) at the N terminus. The
active site in each TGase is marked with a yellow asterisk. This
figure was produced using MOLSCRIPT (36).
|
 |
Figure 2.
Fig. 2. Structural comparison of FTG with human factor
XIII. Stereoviews of the C traces of
FTG and human factor XIII are shown. The superposition was done
using QUANTA97. FTG, human factor XIII, and the activation
peptide are colored blue, red, and green, respectively. The
active site in each TGase is marked with a white asterisk.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
12055-12059)
copyright 2001.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Overproduction of dnaj in escherichia coli improves in vivo solubility of the recombinant fish-Derived transglutaminase.
|
 |
|
Authors
|
 |
K.Yokoyama,
Y.Kikuchi,
H.Yasueda.
|
 |
|
Ref.
|
 |
Biosci Biotechnol Biochem, 1998,
62,
1205-1210.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Tissue-Type transglutaminase from red sea bream (pagrus major). Sequence analysis of the cdna and functional expression in escherichia coli.
|
 |
|
Authors
|
 |
H.Yasueda,
K.Nakanishi,
Y.Kumazawa,
K.Nagase,
M.Motoki,
H.Matsui.
|
 |
|
Ref.
|
 |
Eur J Biochem, 1995,
232,
411-419.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |